Cardiac Stem Cell Therapy Shows Promise for Regenerating Heart Muscle After Attack
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
12 Artikel
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
65-patient trial tested bone marrow stem cells injected directly into damaged heart muscle to restore function in chronic heart failure.
115-patient trial tested CardioCell stem cell treatment against placebo for chronic heart failure patients with promising regenerative approach.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Researchers tested injecting cardiac stem cells directly into heart arteries after heart attacks to promote healing and regeneration.
Researchers tested whether stem cells from healthy hearts could help repair damage in heart attack patients, offering hope for cardiac regeneration.
Large trial tests umbilical cord stem cells to prevent heart failure in heart attack patients with reduced heart function.
Clinical trial tested whether bone marrow stem cells could improve heart function beyond standard bypass surgery alone.
NIDCR-Forscher verglichen Stromazellen aus Knochenmark, Haut, Milz und Fettgewebe, um festzustellen, welche am besten zur Knochenregeneration und Blutbildung beiträgt.
Researchers compared stem cells from arthritis patients versus healthy donors to assess regenerative therapy potential.
Small trial tests autologous stem cells to regenerate damaged knee cartilage in osteoarthritis patients with promising safety profile.
Adipose-derived stem cells combined with platelet-rich plasma evaluated for treating moderate to severe knee osteoarthritis over 2 years.